Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2021 / Jan / Integrated Testing for Blood Disorders
Hematology Hematology Software and hardware

Integrated Testing for Blood Disorders

Integrated anemia and sickle cell disease test yields high sensitivity and accuracy

By Liv Gaskill 01/06/2021 Quick Read (pre 2022) 1 min read

Share

Effective management of blood disorders – such as anemia and sickle cell disease (SCD) – depend on accurate and rapid diagnosis, but lack of affordable, accessible testing makes this difficult in developing countries. Existing diagnostic technology platforms can already detect SCD, but there’s always room for improvement.

Researchers from Case Western Reserve University recognized this opportunity and integrated an anemia test into the Gazelle platform. They then tested samples from 46 patients studied for anemia and SCD (1). The test yielded 100 percent sensitivity and over 92.3 percent specificity for anemia, and 100 percent accuracy for hemoglobin variants.

“The study from Case Western Reserve demonstrates that a software enhancement […] holds the potential to allow our current sickle cell disease test to also check for anemia, which could help clinicians and patients to optimize disease management through a single, low-cost test,” said Patti White (1), co-founder and CEO of Hemex Health.

Newsletters

Receive the latest analytical scientist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

References

  1. Hemex Health (2020). Available at: https://bit.ly/3mj6yrG.

About the Author(s)

Liv Gaskill

During my undergraduate degree in psychology and Master’s in neuroimaging for clinical and cognitive neuroscience, I realized the tasks my classmates found tedious – writing essays, editing, proofreading – were the ones that gave me the greatest satisfaction. I quickly gathered that rambling on about science in the bar wasn’t exactly riveting for my non-scientist friends, so my thoughts turned to a career in science writing. At Texere, I get to craft science into stories, interact with international experts, and engage with readers who love science just as much as I do.

More Articles by Liv Gaskill

Explore More in Analytical Science

Dive deeper into the analytical science. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Case of the Month
Hematology
Case of the Month

January 11, 2022

1 min read

Enriching Our Understanding of Multiple Myeloma
Hematology
Enriching Our Understanding of Multiple Myeloma

February 9, 2022

3 min read

Career Snapshots with Robert Dunn
Hematology
Career Snapshots with Robert Dunn

May 25, 2022

1 min read

Michael Schubert interviews Robert Dunn on working as a biomedical scientist in cytogenetics

A Moment in the Sun
Hematology
A Moment in the Sun

June 23, 2022

4 min read

The decades-long fight for T cells to earn their place in the limelight

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.